Mainz Biomed B.V.

NASDAQ: MYNZ · Real-Time Price · USD
1.77
0.08 (4.73%)
At close: Aug 15, 2025, 12:49 PM

Mainz Biomed B.V. Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
893.99K 895.48K 529.88K 577.35K
Cost of Revenue
319.11K 385.82K 347.73K 399.73K
Gross Profit
574.88K 509.66K 182.15K 177.62K
Operating Income
-18.7M -26.64M -26.17M -9.38M
Interest Income
n/a n/a n/a n/a
Pretax Income
-21.65M -26.3M -26.39M -11.7M
Net Income
-21.65M -26.3M -26.45M -12.07M
Selling & General & Admin
12.77M 17.22M 22.81M 9.41M
Research & Development
5.84M 9.59M 3.66M 466.69K
Other Expenses
656.34K 342.4K -114.05K -320.89K
Operating Expenses
19.27M 27.15M 26.36M 9.56M
Interest Expense
1.08M 809.58K 289.32K 339.17K
Selling & Marketing Expenses
4.7M 3.8M 4.98M 957.52K
Cost & Expenses
19.59M 27.54M 26.7M 9.96M
Income Tax Expense
n/a n/a 65.39K 377.12K
Shares Outstanding (Basic)
968.23K 16.24M 14.16M 7.21M
Shares Outstanding (Diluted)
968.23K 16.24M 14.16M 7.21M
EPS (Basic)
-22.36 -1.62 -1.87 -1.67
EPS (Diluted)
-22.36 -1.62 -1.87 -1.67
EBITDA
-19.56M -25.01M -25.72M -11.28M
EBIT
-20.58M -26.05M -26.1M -11.35M
Depreciation & Amortization
1.02M 1.03M 459.43K 209.9K